SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-24-000354
Filing Date
2024-02-12
Accepted
2024-02-12 16:30:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g10022bdrx_02122024.htm SC 13G 213625
2 ex991to13g10022bdrx_02122024.htm EX-99.1 11685
  Complete submission text file 0000921895-24-000354.txt   226985
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89366 | Film No.: 24620439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11700 W CHARLESTON BLVD 170-659 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD 170-659 LAS VEGAS NV 89135 631-987-0235
Bigger Capital, LLC (Filed by) CIK: 0001996245 (see all company filings)

IRS No.: 900131168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G